厄达替尼哪里买的到？

Erdafitinib is an oral pan-FGFR inhibitor. FGFRs are a family of receptor tyrosine kinases, and genetic mutations that appear in different tumors can cause them to be activated, thereby promoting the survival and proliferation of tumor cells. In April 2019, the FDA approved the first approved targeted drug for metastatic bladder cancer—for the treatment of adult patients with locally advanced or metastatic bladder cancer who carry FGFR3 or FGFR2 mutations and have progressed after platinum-based chemotherapy.

The BLC2001 clinical trial data based on the approval of erdafitinib showed that the ORR of 87 patients with advanced FGFR gene mutation bladder cancer after treatment was 32.2% (CR2.3%, PR29.9%). Later, updated data showed that the ORR of erdafitinib in the treatment of 99 patients with advanced FGFR gene-mutated bladder cancer reached 40% (CR3%, PR37%), and the ORR of 22 patients after immunotherapy was as high as 59%. It can be seen that the effect has been effectively verified.

Where can I buy erdafitinib?

Erdafitinib is already on the market in Hong Kong. Patients in need can go to Hong Kong to purchase erdafitinib. According to Medical Companion Travel, the specification of erdafitinib imported into Hong Kong is 4mg*28 tablets and the price is about $106,500. Please consult Medical Companion Travel for the specific price! 

If it is inconvenient for you to go to Hong Kong to purchase, the most reliable way is to purchase it through a formal overseas medical service institution in China, which will sign a protection contract for you. The medicine and money will not be handled by you, and will be mailed to the patient by direct mail, guaranteeing 100% authenticity!

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: